Human Immunology News Volume 11.28 | Jul 18 2023

    0
    17








    2023-07-18 | HIN 11.28


    Human Immunology News by STEMCELL Technologies
    Vol. 11.28 – 18 July, 2023
    TOP STORY

    A Distinct Stimulatory cDC1 Subpopulation Amplifies CD8+ T Cell Responses in Tumors for Protective Anti-Cancer Immunity

    Investigators used imaging-based deep learning to identify intratumoral type 1 conventional dendritic cells (cDC1)-CD8+ T cell clustering as a unique feature of protective anti-cancer immunity.
    [Cancer Cell]

    Full ArticleGraphical Abstract
    View tips on how to choose efficient technologies for your research.
    PUBLICATIONSRanked by the impact factor of the journal

    Induction of Bronchus-Associated Lymphoid Tissue Is an Early Life Adaptation for Promoting Human B Cell Immunity

    Researchers showed that bronchus-associated lymphoid tissue, containing B cell follicles, CD4+ T cells and functionally active germinal centers, develop during infancy.
    [Nature Immunology]

    AbstractPress Release

    A Three-Stage Developmental Pathway for Human Vγ9Vδ2 T Cells within the Postnatal Thymus

    The authors used high-dimensional flow cytometry, transcriptomic analysis, functional assays, and precursor-product experiments to define the development pathway of Vγ9Vδ2 T cells in the postnatal thymus.
    [Science Immunology]

    AbstractPress Release

    Gluten Induces Rapid Reprogramming of Natural Memory αβ and γδ Intraepithelial T Cells to Induce Cytotoxicity in Celiac Disease

    Investigators performed multiplexed single-cell analysis of intestinal and gluten-induced peripheral blood T cells from patients in different celiac disease states and healthy controls.
    [Science Immunology]

    Full Article

    Multimodal Immune Cell Phenotyping in GI Biopsies Reveals Microbiome-Related T Cell Modulations in Human GvHD

    Scientists highlighted the pathophysiological importance of expanded CD8 T cell clones in the progression of acute graft-versus-host disease (GvHD) toward more severe clinical manifestations.
    [Cell Reports Medicine]

    Full ArticleGraphical Abstract

    Low Level of ARID1A Contributes to Adaptive Immune Resistance and Sensitizes Triple-Negative Breast Cancer to Immune Checkpoint Inhibitors

    The authors evaluated the role of ARID1A among a series of epigenetic modulators in triple-negative breast cancer and explored how low ARID1A expression contributed to adaptive immune resistance.
    [Cancer Communications]

    Full Article

    Accumulation of Tissue-Resident Natural Killer Cells, Innate Lymphoid Cells, and CD8+ T Cells towards the Center of Human Lung Tumors

    Scientists identified an accumulation of tissue-resident lymphocytes including tissue-resident NK cells and CD8+ tissue-resident memory T cells toward the center of human non-small cell lung carcinomas.
    [OncoImmunology]

    Full Article

    Human Granzyme K Is a Feature of Innate T Cells in Blood, Tissues, and Tumors, Responding to Cytokines Rather Than TCR Stimulation

    Researchers showed that, in humans, granzyme K (GzmK) was predominantly expressed by innate-like lymphocytes, as well as a newly identified population of GzmK+CD8+ non– mucosal-associated invariant T cells with innate-like characteristics.
    [Journal of Immunology]

    Abstract

    Human β-Defensins Are Correlated with the Immune Infiltration and Regulated by Vitamin D3 in Periodontitis

    Investigators explored the correlation between human β-defensins and immune infiltration in periodontitis and determined whether it is regulated by vitamin D3.
    [Journal Of Periodontal Research]

    Abstract
    Facts above claims. Three scientists peer reviewed a life science vendor to get to the truth. See for yourself.
    REVIEWS

    Resistance to Immune Checkpoint Therapies by Tumour-Induced T Cell Desertification and Exclusion: Key Mechanisms, Prognostication, and New Therapeutic Opportunities

    The authors dive into critical mechanisms by which cancer cells induce T cell ‘desertification’ and ‘exclusion’ in immune checkpoint therapies refractory tumors.
    [British Journal of Cancer]

    Full Article

    Human Neutrophil Fc Gamma Receptors: Different Buttons for Different Responses

    Investigators describe the major Fcγ receptors expressed on human neutrophils and discuss how each Fcγ receptor activates a choice of signaling pathways to stimulate particular neutrophil responses.
    [Journal of Leukocyte Biology]

    Abstract

    Insight on Immune Cells in Rejection and Infection Postlung Transplant

    Scientists provide a concise overview of the role of immune cells in rejection and infection after lung transplantation.
    [Immunity Inflammation And Disease]

    Full Article
    INDUSTRY AND POLICY NEWS

    Allen Institute for Immunology Partners with Lilly to Better Understand Autoimmune Disease

    The Allen Institute for Immunology has announced that researchers and staff will collaborate with private industry researchers to aid in the detailed, molecular understanding of disease, in service of developing new treatments and therapies to improve human health.
    [Allen Institute]

    Press Release

    UB, Partner Awarded $3 Million NIH Grant to Study Immune Cell Therapy for Tumors

    The National Cancer Institute awarded Dr. Ruogang Zhao, professor of biomedical engineering at the University at Buffalo (UB), and a colleague a five-year, $3 million R01 research grant to study immune cell therapy for solid tumors.
    [University at Buffalo]

    Press Release
    FEATURED EVENT

    2023 Lung Development, Injury, and Repair Seminar GRC

    August 12 – 13, 2023
    Waterville Valley, New Hampshire, United States

    > See All Events

    JOB OPPORTUNITIES

    Executive Medical Director – Radiopharmaceuticals

    Novartis – East Hanover, New Jersey, United States

    Postdoctoral Fellow – Tumor Microenvironment in Gastrointestinal and Liver Cancer

    Centre for Oncology and Immunology – Hong Kong, Hong Kong

    Faculty Positions – Advanced Immunochemical Studies

    ShanghaiTech University – Shanghai, China

    Postdoctoral Position – Immune Modulation in Cancer and Microbiome

    The Hospital of the University of Munich – Munich, Germany

    Postdoctoral Fellow – Tumor Microenvironment

    The University of Texas MD Anderson Cancer Center- Houston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Human Immunology News Twitter